The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty

Skedgel, Chris ORCID: https://orcid.org/0000-0003-4989-8846, Goeree, Ron, Pleasance, Sue, Thompson, Kara, O'Brien, Bernie and Anderson, David (2007) The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty. The Journal of Bone and Joint Surgery (American), 89 (4). pp. 819-828. ISSN 0021-9355

Full text not available from this repository. (Request a copy)

Abstract

Although the risk of thromboembolism after total hip arthroplasty continues beyond hospital discharge, the cost-effectiveness of extending prophylaxis beyond hospitalization is unclear. We compared the cost-effectiveness of an extended duration of antithrombotic prophylaxis following total hip arthroplasty, with use of low-molecular-weight heparin or warfarin administered for twenty-eight days beyond hospital discharge, in terms of incremental cost per quality-adjusted life year gained.

Item Type:	Article
Uncontrolled Keywords:	anticoagulants,arthroplasty, replacement, hip,cost-benefit analysis,heparin, low-molecular-weight,humans,thromboembolism,time factors,warfarin,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Health Economics Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	Pure Connector
Date Deposited:	04 Feb 2015 12:42
Last Modified:	06 Feb 2023 15:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/51941
DOI:	10.2106/JBJS.F.00092

Actions (login required)

View Item